Yes, we are 10 days from the hockey stick curve growth. I

New Post Public Reply Private Reply Replies (0) Message Board
Rubraquercus misiu143 #21910
504
Yes, we are 10 days from the hockey stick curve growth. I think we did slow it down and that was long enough to get some good data from others on how to proceed and slow the mortality (like Chloroquine) and slow the impact on the system. Time will tell very soon.

To the rest of the board, my apologies for not posting sooner (limited posts) and for not finding the GVHD trial. I mistakenly assumed I could search leronlimab and find them all, nope. Here is what I discovered, Leronlimab will get 3 hits, Cytodyn gets 14 hits, pro 140 gets 29 hits, and Vyrologix gets zero hits. Some think .gov is a waist of time, of course, I think those folks are defending the indefensible failures of the company to get it together. NP apparently would rather pump the story with $20k payments to proactive instead of tending the knitting and updated trials and getting press releases correct on basics like trial protocols requiring carbo in combo. They pay Amerex a lot of money for what? So the trials are not updated for months at a time? I am long about 1,200 shares of hard earned money and hoping to keep it at the very least...

I suspect we will see a deal overseas asap, compassionate use asap, IND confirmed asap, and the coup de grace will be a finance deal a few weeks after all that. BLA is a bid deal, the delays are very troubling. And the double blind placebo is a 2:1 ratio of leronlimab:placebo. This is rare and is only being used to help patients get the drug. It is harder on the company to prove efficacy. Unequal randomization (e.g. 2:1 or 3:1) is done quite rarely. There are some occasions when it is justified. Such a randomization needs to overcome scientific and ethical problems like ARDS lung damage if the patients don't get the drug.

Peace out

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 1

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 2

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 2

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 0

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Sentiment Shifts: Nasdaq Rises Despite Fear Index

Updated Category News Views 220

Positive Movement in the Nasdaq Index The stock market witnessed promising trends as the Nasdaq Composite surged over 100 points. This optimism is widely attributed to robust performances from banks and significant corporations. Investors are bolstered by hope for mixed economic recovery as growth prospects continue to emerge. Impact of Strong Earnings Major financial...

Continue Reading
Upcoming Shareholders' Meeting and Tarkett's Growth Plans

Updated Category News Views 169

Investor Insights on Tarkett's Upcoming Shareholders' Meeting Tarkett, a prominent player in the flooring industry, is gearing up for its Combined Shareholders' Meeting scheduled for a Thursday in June. Stakeholders will gather to discuss pivotal updates and future directions for the company. Details of the Shareholders' Meeting Set to commence at 9:30 a.m., the meeting...

Continue Reading
TT Trade Surveillance Wins Best Solution Award Again

Updated Category News Views 123

TT Trade Surveillance Achieves Recognition in Capital Markets Trading Technologies International, Inc. (TT), a prominent player in the global capital markets technology landscape, has recently made headlines by receiving prestigious awards for its TT Trade Surveillance platform, underscoring its excellence in trade surveillance solutions. This platform has just been...

Continue Reading
Foresight Group Holdings Limited Completes Share Buyback

Updated Category News Views 162

Foresight Group Holdings Limited Completes Share Buyback Programme On November 20, 2025, Foresight Group Holdings Limited, a prominent investment manager specializing in real assets, announced its ongoing efforts as part of the newly initiated share buyback program. This strategic move has garnered attention from investors looking to engage further with the company....

Continue Reading
Itron Inspire 2025: Unveiling a New Era in Resource Management

Updated Category News Views 177

Exciting Innovations at Itron Inspire 2025 Itron, Inc. (NASDAQ: ITRI) is set to host its much-anticipated event, Itron Inspire 2025, where the focus is on turning the future of energy, water, and smart cities into reality. Held in a collaborative environment, this event aims to bring together industry professionals to tackle the most pressing challenges in resource...

Continue Reading